The effect of astaxanthin supplementation on inflammatory markers, oxidative stress indices, lipid profile, uric acid level, blood pressure, endothelial function, quality of life, and disease symptoms in heart failure subjects
An 8-week randomized, placebo-controlled trial testing 20 mg/day of astaxanthin in patients with heart failure, evaluating inflammatory markers, oxidative stress, lipid profile, blood pressure, endothelial function, and quality of life as a multi-endpoint safety and efficacy assessment in a cardiac population.
Evidence
5/10
Emerging Evidence
Sample
—
subjects
Duration
8 weeks
study period
Journal
Trials
Jun 2024
Key Findings
- 01
Tested astaxanthin 20 mg/day for 8 weeks in a heart failure population
- 02
Multi-endpoint design covering inflammation, oxidative stress, lipids, blood pressure, and endothelial function
- 03
Represents one of the few RCTs of astaxanthin in a diagnosed cardiac patient population rather than healthy volunteers
Structured Methods
- Study Design
- Clinical Trial
- Sample Size
- Not reported
- Study Duration
- 8 weeks
- Methodology
- Not reported
- Limitations
- Single trial in a specific patient population (heart failure); findings in this population do not necessarily generalize to healthy adults using astaxanthin for general antioxidant support.
Citations & References
Unknown authors (2024). The effect of astaxanthin supplementation on inflammatory markers, oxidative stress indices, lipid profile, uric acid level, blood pressure, endothelial function, quality of life, and disease symptoms in heart failure subjects. Trials. https://doi.org/10.1186/s13063-024-08339-8
Sample member
Longevity Operator
One number for your longevity journey.
FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.
- Metabolic
- Hormonal
- Cardiovascular
- Brain / Cognitive
- Sleep
- Musculoskeletal
- Gut
- Immunity / Inflammation